Details
Stereochemistry | ACHIRAL |
Molecular Formula | C18H13ClFN3 |
Molecular Weight | 325.767 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CC1=NC=C2CN=C(C3=C(F)C=CC=C3)C4=C(C=CC(Cl)=C4)N12
InChI
InChIKey=DDLIGBOFAVUZHB-UHFFFAOYSA-N
InChI=1S/C18H13ClFN3/c1-11-21-9-13-10-22-18(14-4-2-3-5-16(14)20)15-8-12(19)6-7-17(15)23(11)13/h2-9H,10H2,1H3
Molecular Formula | C18H13ClFN3 |
Molecular Weight | 325.767 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:48:03 UTC 2023
by
admin
on
Fri Dec 15 15:48:03 UTC 2023
|
Record UNII |
R60L0SM5BC
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Code | English | ||
|
Systematic Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
DEA NO. |
2884
Created by
admin on Fri Dec 15 15:48:04 UTC 2023 , Edited by admin on Fri Dec 15 15:48:04 UTC 2023
|
||
|
WHO-VATC |
QN05CD08
Created by
admin on Fri Dec 15 15:48:04 UTC 2023 , Edited by admin on Fri Dec 15 15:48:04 UTC 2023
|
||
|
FDA ORPHAN DRUG |
514115
Created by
admin on Fri Dec 15 15:48:04 UTC 2023 , Edited by admin on Fri Dec 15 15:48:04 UTC 2023
|
||
|
LIVERTOX |
NBK548691
Created by
admin on Fri Dec 15 15:48:04 UTC 2023 , Edited by admin on Fri Dec 15 15:48:04 UTC 2023
|
||
|
FDA ORPHAN DRUG |
373912
Created by
admin on Fri Dec 15 15:48:04 UTC 2023 , Edited by admin on Fri Dec 15 15:48:04 UTC 2023
|
||
|
WHO-ESSENTIAL MEDICINES LIST |
1.3
Created by
admin on Fri Dec 15 15:48:04 UTC 2023 , Edited by admin on Fri Dec 15 15:48:04 UTC 2023
|
||
|
FDA ORPHAN DRUG |
622817
Created by
admin on Fri Dec 15 15:48:04 UTC 2023 , Edited by admin on Fri Dec 15 15:48:04 UTC 2023
|
||
|
FDA ORPHAN DRUG |
507615
Created by
admin on Fri Dec 15 15:48:04 UTC 2023 , Edited by admin on Fri Dec 15 15:48:04 UTC 2023
|
||
|
NCI_THESAURUS |
C1012
Created by
admin on Fri Dec 15 15:48:04 UTC 2023 , Edited by admin on Fri Dec 15 15:48:04 UTC 2023
|
||
|
FDA ORPHAN DRUG |
217405
Created by
admin on Fri Dec 15 15:48:04 UTC 2023 , Edited by admin on Fri Dec 15 15:48:04 UTC 2023
|
||
|
WHO-ATC |
N05CD08
Created by
admin on Fri Dec 15 15:48:04 UTC 2023 , Edited by admin on Fri Dec 15 15:48:04 UTC 2023
|
||
|
NDF-RT |
N0000175694
Created by
admin on Fri Dec 15 15:48:04 UTC 2023 , Edited by admin on Fri Dec 15 15:48:04 UTC 2023
|
||
|
FDA ORPHAN DRUG |
508215
Created by
admin on Fri Dec 15 15:48:04 UTC 2023 , Edited by admin on Fri Dec 15 15:48:04 UTC 2023
|
||
|
WHO-ESSENTIAL MEDICINES LIST |
8.4
Created by
admin on Fri Dec 15 15:48:04 UTC 2023 , Edited by admin on Fri Dec 15 15:48:04 UTC 2023
|
||
|
FDA ORPHAN DRUG |
277809
Created by
admin on Fri Dec 15 15:48:04 UTC 2023 , Edited by admin on Fri Dec 15 15:48:04 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
DTXSID5023320
Created by
admin on Fri Dec 15 15:48:04 UTC 2023 , Edited by admin on Fri Dec 15 15:48:04 UTC 2023
|
PRIMARY | |||
|
6960
Created by
admin on Fri Dec 15 15:48:04 UTC 2023 , Edited by admin on Fri Dec 15 15:48:04 UTC 2023
|
PRIMARY | RxNorm | ||
|
1443599
Created by
admin on Fri Dec 15 15:48:04 UTC 2023 , Edited by admin on Fri Dec 15 15:48:04 UTC 2023
|
PRIMARY | |||
|
4497
Created by
admin on Fri Dec 15 15:48:04 UTC 2023 , Edited by admin on Fri Dec 15 15:48:04 UTC 2023
|
PRIMARY | |||
|
MIDAZOLAM
Created by
admin on Fri Dec 15 15:48:04 UTC 2023 , Edited by admin on Fri Dec 15 15:48:04 UTC 2023
|
PRIMARY | |||
|
6932
Created by
admin on Fri Dec 15 15:48:04 UTC 2023 , Edited by admin on Fri Dec 15 15:48:04 UTC 2023
|
PRIMARY | |||
|
R60L0SM5BC
Created by
admin on Fri Dec 15 15:48:04 UTC 2023 , Edited by admin on Fri Dec 15 15:48:04 UTC 2023
|
PRIMARY | |||
|
C62049
Created by
admin on Fri Dec 15 15:48:04 UTC 2023 , Edited by admin on Fri Dec 15 15:48:04 UTC 2023
|
PRIMARY | |||
|
D008874
Created by
admin on Fri Dec 15 15:48:04 UTC 2023 , Edited by admin on Fri Dec 15 15:48:04 UTC 2023
|
PRIMARY | |||
|
SUB08950MIG
Created by
admin on Fri Dec 15 15:48:04 UTC 2023 , Edited by admin on Fri Dec 15 15:48:04 UTC 2023
|
PRIMARY | |||
|
59467-70-8
Created by
admin on Fri Dec 15 15:48:04 UTC 2023 , Edited by admin on Fri Dec 15 15:48:04 UTC 2023
|
PRIMARY | |||
|
Midazolam
Created by
admin on Fri Dec 15 15:48:04 UTC 2023 , Edited by admin on Fri Dec 15 15:48:04 UTC 2023
|
PRIMARY | |||
|
261-774-5
Created by
admin on Fri Dec 15 15:48:04 UTC 2023 , Edited by admin on Fri Dec 15 15:48:04 UTC 2023
|
PRIMARY | |||
|
DB00683
Created by
admin on Fri Dec 15 15:48:04 UTC 2023 , Edited by admin on Fri Dec 15 15:48:04 UTC 2023
|
PRIMARY | |||
|
m7531
Created by
admin on Fri Dec 15 15:48:04 UTC 2023 , Edited by admin on Fri Dec 15 15:48:04 UTC 2023
|
PRIMARY | Merck Index | ||
|
3342
Created by
admin on Fri Dec 15 15:48:04 UTC 2023 , Edited by admin on Fri Dec 15 15:48:04 UTC 2023
|
PRIMARY | |||
|
6931
Created by
admin on Fri Dec 15 15:48:04 UTC 2023 , Edited by admin on Fri Dec 15 15:48:04 UTC 2023
|
PRIMARY | |||
|
4192
Created by
admin on Fri Dec 15 15:48:04 UTC 2023 , Edited by admin on Fri Dec 15 15:48:04 UTC 2023
|
PRIMARY | |||
|
CHEMBL655
Created by
admin on Fri Dec 15 15:48:04 UTC 2023 , Edited by admin on Fri Dec 15 15:48:04 UTC 2023
|
PRIMARY | |||
|
7581
Created by
admin on Fri Dec 15 15:48:04 UTC 2023 , Edited by admin on Fri Dec 15 15:48:04 UTC 2023
|
PRIMARY | |||
|
6751
Created by
admin on Fri Dec 15 15:48:04 UTC 2023 , Edited by admin on Fri Dec 15 15:48:04 UTC 2023
|
PRIMARY | |||
|
100000080626
Created by
admin on Fri Dec 15 15:48:04 UTC 2023 , Edited by admin on Fri Dec 15 15:48:04 UTC 2023
|
PRIMARY | |||
|
R60L0SM5BC
Created by
admin on Fri Dec 15 15:48:04 UTC 2023 , Edited by admin on Fri Dec 15 15:48:04 UTC 2023
|
PRIMARY | |||
|
1802
Created by
admin on Fri Dec 15 15:48:04 UTC 2023 , Edited by admin on Fri Dec 15 15:48:04 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
METABOLIC ENZYME -> SUBSTRATE | |||
|
METABOLIC ENZYME -> SUBSTRATE | |||
|
BINDER->LIGAND |
|
||
|
METABOLIC ENZYME -> SUBSTRATE | |||
|
TRANSPORTER -> INHIBITOR | |||
|
METABOLIC ENZYME -> INHIBITOR | |||
|
METABOLIC ENZYME -> SUBSTRATE |
|
||
|
SALT/SOLVATE -> PARENT |
|
||
|
METABOLIC ENZYME -> SUBSTRATE | |||
|
SALT/SOLVATE -> PARENT |
|
||
|
METABOLIC ENZYME -> INHIBITOR | |||
|
METABOLIC ENZYME -> SUBSTRATE |
Related Record | Type | Details | ||
---|---|---|---|---|
|
METABOLITE -> PARENT |
|
||
|
METABOLITE ACTIVE -> PARENT |
|
||
|
METABOLITE -> PARENT |
|
||
|
METABOLITE -> PARENT | |||
|
METABOLITE ACTIVE -> PARENT |
|
||
|
METABOLITE -> PARENT |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
|
Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
---|---|---|---|---|---|---|
Volume of Distribution | PHARMACOKINETIC |
|
|
|||
Biological Half-life | PHARMACOKINETIC |
|
|
|||